LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab.

Source:http://linkedlifedata.com/resource/pubmed/id/18086797

J. Clin. Oncol. 2008 Jan 20 26 3 447-54

Download in:

View as

Triples

General Info

PMID
18086797